Pattabiraman et al., 2013 - Google Patents
MRP4-mediated regulation of intracellular cAMP and cGMP levels in trabecular meshwork cells and homeostasis of intraocular pressurePattabiraman et al., 2013
View HTML- Document ID
- 15755475734344907027
- Author
- Pattabiraman P
- Pecen P
- Rao P
- Publication year
- Publication venue
- Investigative Ophthalmology & Visual Science
External Links
Snippet
Purpose.: Multidrug, resistance-associated protein-4 (MRP4) is a membrane transporter that regulates the cellular efflux of cyclic nucleotides (cAMP and cGMP) involved in various physiologic responses. This study examined the expression and distribution of MRP4 in the …
- 210000001585 Trabecular Meshwork 0 title abstract description 105
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pattabiraman et al. | MRP4-mediated regulation of intracellular cAMP and cGMP levels in trabecular meshwork cells and homeostasis of intraocular pressure | |
| Eelen et al. | Role of glutamine synthetase in angiogenesis beyond glutamine synthesis | |
| Nowell et al. | Chronic inflammation imposes aberrant cell fate in regenerating epithelia through mechanotransduction | |
| Puri et al. | Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway | |
| Zhang et al. | Sphingosine kinase 2 (Sphk2) regulates platelet biogenesis by providing intracellular sphingosine 1-phosphate (S1P) | |
| Sherpa et al. | Sensory primary cilium is a responsive cAMP microdomain in renal epithelia | |
| Di Mise et al. | Activation of Calcium-Sensing Receptor increases intracellular calcium and decreases cAMP and mTOR in PKD1 deficient cells | |
| Kleinschmidt et al. | Rgnef promotes ovarian tumor progression and confers protection from oxidative stress | |
| JP2015172054A (en) | Modulation of axon degeneration | |
| Ibarra et al. | Type I but not type II calreticulin mutations activate the IRE1α/XBP1 pathway of the unfolded protein response to drive myeloproliferative neoplasms | |
| Zhang et al. | Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes | |
| Woo et al. | Retinotopic mapping requires focal adhesion kinase-mediated regulation of growth cone adhesion | |
| KR101719966B1 (en) | EPH receptor expression in tumor stem cells | |
| Stewen et al. | Eph-ephrin signaling couples endothelial cell sorting and arterial specification | |
| Laufman et al. | Deficiency of the Cog8 subunit in normal and CDG‐derived cells impairs the assembly of the COG and Golgi SNARE complexes | |
| Liu et al. | NMNAT promotes glioma growth through regulating post-translational modifications of P53 to inhibit apoptosis | |
| Lin et al. | Nrf2 inhibition affects cell cycle progression during early mouse embryo development | |
| US20170202910A1 (en) | Differentiation marker and differentiation control of eye cell | |
| KR20110022000A (en) | Methods of treating meiosis kinesin-associated disease | |
| Giordani et al. | The human Smoothened inhibitor PF-04449913 induces exit from quiescence and loss of multipotent Drosophila hematopoietic progenitor cells | |
| Spurrell et al. | Vav1 regulates the migration and adhesion of dendritic cells | |
| Hung et al. | Wnt5b integrates Fak1a to mediate gastrulation cell movements via Rac1 and Cdc42 | |
| Zheng et al. | Involvement of rho-kinase pathway in contractile activity of rabbit RPE cells in vivo and in vitro | |
| US20160052918A1 (en) | Small compounds targeting tacc3 | |
| Ashwinbalaji et al. | SB772077B, A new rho kinase inhibitor enhances aqueous humour outflow facility in human eyes |